CHRM3 and central nervous system cancer: Given the combination of interactions of CHRM3-AS2 and miR-370-5p with KLF4 expression, we suggest that miR-370-5p-mediated KLF4 expression is part of the underlying mechanism of action of CHRM3-AS2 on glioma cells.